English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52721287    ???header.onlineuser??? :  667
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yabe d"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-5 of 5  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2025-05-20 Accelerating innovation and ensuring the thoughtful withdrawal of lifeline medicines for people living with diabetes in Asia Seino, Y;Yabe, D;Choi, SH;Hsu, CC;Huang, CN;Khasag, A;Tan, K;Ueki, K;Yamada, Y;Akanov, ZA;Kadowaki, T
國家衛生研究院 2023-08-31 Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia Vistisen, D; Carstensen, B; Elisabetta, P; Lanzinger, S; Tan, ECH; Yabe, D; Kim, DJ; Sheu, WHH; Melzer-Cohen, C; Holl, RW; Núñez, J; Ha, KH; Halvorsen, S; Langslet, G; Karasik, A; Nyström, T; Niskanen, L; Guleria, S; Klement, R; Carrasco, M; Foersch, J; Shay, C; Koeneman, L; Hoti, F; Farsani, SF; Khunti, K; Zaccardi, F; Subramanian, A; Nirantharakumar, K; EMPRISE EU and East Asia Study Group
臺大學術典藏 2020-05-25T02:46:08Z Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials Yabe D.;Yasui A.;Ji L.;Lee M.-K.;Ma R.C.W.;Tien-Jyun Chang;Okamura T.;Zeller C.;Kaspers S.;Lee J.;Kohler S.;Seino Y.; Yabe D.; Yasui A.; Ji L.; Lee M.-K.; Ma R.C.W.; TIEN-JYUN CHANG; Okamura T.; Zeller C.; Kaspers S.; Lee J.; Kohler S.; Seino Y.
臺大學術典藏 2020-05-25T02:46:08Z Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials Yabe D.;Yasui A.;Ji L.;Lee M.-K.;Ma R.C.W.;Tien-Jyun Chang;Okamura T.;Zeller C.;Kaspers S.;Lee J.;Kohler S.;Seino Y.; Yabe D.; Yasui A.; Ji L.; Lee M.-K.; Ma R.C.W.; TIEN-JYUN CHANG; Okamura T.; Zeller C.; Kaspers S.; Lee J.; Kohler S.; Seino Y.
中山醫學大學 2020 Diabetes and COVID-19: IDF perspective in the Western Pacific region Hwang, Y; Khasag, A; Jia, WP; Jenkins, A; Huang, CN; Yabe, D; Kim, DM; Kadowaki, T; Lee, MK

Showing items 1-5 of 5  (1 Page(s) Totally)
1 
View [10|25|50] records per page